Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
201378 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 5.51
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial | Researchclopedia